Hims & Hers Shares Slip After Q2 Loss, Regulatory Scrutiny Persists

Shares of Hims & Hers Health (NYSE: HIMS) slipped roughly 3% on Tuesday, a sharp after‑hours decline that followed a 7...

Read story →